Abstract:Both reversible noncovalent inhibitors and irreversible covalent inhibitors targeting tyrosine kinases have their disadvantages. The reversible covalent inhibitors with electrophilic group cyanoacrylamide as warheads reacting with cysteine residues could solve the dilemmas. However, there are still several unresolved issues regarding the electrophilic groups. In this manuscript, a series of EGFR inhibitors with double electron-withdrawing substituents introduced into the C-alpha position on the olefin bond were designed and synthesized. The binding structures and characteristics of inhibitors with the kinase in both the first noncovalent binding phase and the second covalent binding step were explored and combined with molecular docking and molecular dynamics simulations. Then, the reverse beta-elimination reactions of the thiol-Michael adducts were investigated by applying density functional theory calculations. In addition, the effects of different electrophilic substituents of C-alpha on the binding between the inhibitors and kinase were elucidated. The results suggested that the electrophilicity and size of the electron-withdrawing groups play an important role in the specific interactions during the reaction. The compounds with the electron-withdrawing groups that had medium electrostatic and steric complementarity to the kinase active site could cooperatively stabilize the complexes and showed relatively good potent activities in the kinase assay experiment. The mechanical and structural information in this study could enhance our understanding of the functioning of the electron-withdrawing groups in the covalent inhibitors. The results might help to design efficient cysteine targeting inhibitors in the future.

Design and Synthesis of Novel Potassium Channel Openers and QSAR Studies

Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives As Potent and Selective P21-Activated Kinase 4 (PAK4) Inhibitors

Design, Synthesis and Biological Activity of Pyrazolo[1,5-A]pyrimidin-7(4h)-ones As Novel Kv7/KCNQ Potassium Channel Activators

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design, Synthesis and Biological Activities of 2,3-Dihydroquinazolin-4(1h)-one Derivatives As TRPM2 Inhibitors.

Structure-based discovery of potassium channel blockers from natural products: virtual screening and electrophysiological assay testing.

Design, Synthesis and Biological Activities of Benzo[d]imidazo[1,2-A]imidazole Derivatives As TRPM2-specfic Inhibitors

Current strategies for the discovery of K+ channel modulators.

Design, Synthesis and Biological Evaluation of Novel 5-Methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole Derivatives As Potent Potassium-Competitive Acid Blockers.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Diversity-oriented synthesis of marine polybrominated diphenyl ethers as potential KCNQ potassium channel activators

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Structure-Based Design and Synthesis of Novel Type Quinoline As Secretory Pla(2) Inhibitors

Potassium Channels: Structures, Diseases, and Modulators

Computational engineering of water-soluble human potassium ion channels through QTY transformation

Rational Design and Synthesis of 3-Morpholine Linked Aromatic-Imino-1H-Indoles as Novel Kv1.5 Channel Inhibitors Sharing Vasodilation Effects

Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions

Exploring Chemical Substructures Essential for HERG K(+) Channel Blockade by Synthesis and Biological Evaluation of Dofetilide Analogues.

New Potential Calcium Channel Modulators: Design and Synthesis of Compounds Containing Two Pyridine, Pyrimidine, Pyridone, Quinoline and Acridine Units under Microwave Irradiation.

Discovery of a novel K V 7.2/7.3 channels agonist for the treatment of neuropathic pain

Computational methods for unlocking the secrets of potassium channels: Structure, mechanism, and drug design